Links & Resources
- Here’s my mentioned educational segment on KRR
- In case you missed it: Here’s Marc Lichtenfeld on biotech’s 2017 outlook
Welcome back to another episode…To start off today’s stream of questions, I explain to listeners one of the biggest misconceptions in investing.The key to investing in any stock (not just the ones I recommend) comes down to just one simple trick – patience. Many listeners have learned the hard way so I wanted to fully address this once and for all.Its extremely important that investors take their time on placing their bets. Meaning, if you do believe in a stock’s long-term position, don’t make a FULL investment all on the same day.Tune in as I explain how this strategy is one of the best ways to avoid volatility in the markets. I guarantee your returns will see better results.I then revisit my position on a stock that’s been beaten down tremendously. This stock was considered “the darling” of the biotech industry a little over a year ago. It went from being loved by analysts across the board, to now – hated.I’ll be explaining why this biotech pioneer has the potential to rebound over the next 12 to 18 months.Moving on to the next question, I talk about one of today’s biggest trends – Marijuana. David, a Colorado local, says the marijuana industry is booming and asks if now is the perfect time to invest…I couldn’t disagree anymore.If you own any marijuana stocks, be sure to listen as I break down the sector. Although we’ve seen a recent run-up in stock prices, I believe the industry will continue to face huge headwinds. These stocks are simply trades… NOT investments.And finally, to end the episode, it’s Nike (NKE) vs. Under Armour (UA). Tune in as I pick my favorite out of the two for 2017.Other topics include: A sneak peek for next week’s Wall Street Unplugged with CEO of Blackbird Energy (BBI.V), KKR‘s future earnings, and whether it’s too late to get in on Northern Dynasty (NAK).Special thanks to Roland, Brandon, Matt, David, Dave, Nate, and Steve.Keep the questions coming!
Read the signs. Beat the market.
The market intelligence you need to invest one step ahead. Go beyond the headlines. Invest with an insider’s edge.
More about Podcast
Should you buy Cerebras on this pullback?
Cerebras (CBRS) is sinking after its earnings miss—is it a buying opportunity? Plus, here's what's really driving Trump's sudden shift on Iran… 2 stocks for your humanoid robot watchlist… And politicians need to change the data center narrative.
Stop believing this lie about the U.S. dollar
Think the U.S. dollar isn't backed by anything? Think again. Plus, inflation is still hot—will the Fed do anything about it? … CoreWeave (CRWV) and Super Micro (SMCI) earnings… Nvidia’s (NVDA) $500B announcement… And the gold rally.
This tiny copper explorer just unlocked a multibillion-dollar opportunity
Ivan Bebek, CEO of Coppernico Metals (CPPMF), breaks down how a new permit completely changes the company's story… why mining giants are betting on Coppernico… what investors can expect over the next 18 months… and the stock's enormous upside potential.
Is SpaceX a buy on its pullback?
Should you buy SpaceX (SPCX) as shares pull back? Plus, a volatile earnings pattern… Hyperscaler capex is paying off… Disney (DIS) is uninvestable… Why is AMD (AMD) down on solid earnings? … And a political headwind for data centers.
More from Frank Curzio
Could South Korea trigger another 2008 crash?
South Korea's meltdown could spread to the U.S. market. Plus, did a hedge fund cause the AI crash? … Which hyperscaler stock is most attractive here?... And steer clear of SpaceX (SPCX) until after this event.
BlackRock and Meta’s $12B bond deal changes the AI landscape
Inside BlackRock's (BLK) historic bond deal funding Meta's (META) next data center. Plus, a watchlist of stocks for the pullback… These "non-AI" stocks are thriving… Energy bull should look offshore… Fauci's hearing… The Fed meeting… Tim Cook… And more.
Are smarter AI models creating a cyber threat?
OpenAI's HuggingFace debacle: Is AI a cybersecurity risk? Plus, SuperMicro's (SMCI) margins… Open-source vs. closed-source AI models… 2 no-brainer AI power winners… The sector with the most AI risk… China's market manipulation… And stay cautious on SpaceX (SPCX).
How DigiPower X’s $1B Cerebras deal is powering execution
DigiPower X (DGXX) CEO Michel Amar breaks down the company's milestone contract with Cerebras (CBRS)… its AI stack roadmap, from real estate to GPU-as-a-service… key catalysts through 2026… and why DigiPower X is in a league of its own.
Is IBM a buy after its worst day in decades?
IBM's (IBM) worst day in 58 years—is it a buying opportunity? Plus, Fed Chair Warsh's testimony… The odds of a rate hike dropped significantly… Two AI buys… The perfect backdrop for big banks… And Wrap's (WRAP) growing TAM.
How much longer can this bull market last?
Meb Faber, cofounder and chief investment officer of Cambria Investment Management, breaks down his new book on the rise of the 250-year bull market… and how much longer it can last. Plus, why U.S. investors should look abroad.
Latest episodes
